British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
Консенсусные рекомендации Британской ассоциации психофармакологии по применению психотропных препаратов в период до зачатия, во время беременности и в послеродовом периоде, 2017 год
2017-04-25
SCID: 54.1/hqv4vy9t
Discuss with AI
breastfeedingin utero exposureperinatal mental healthpregnancypsychotropic medication
Figures from the paper
Abstract (AI)
Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge for clinicians and women with mental health problems, owing to the uncertainties around risks of the illness itself to mother and fetus/infant, effectiveness of medications in pregnancy and risks to the fetus/infant from in utero exposure or via breast milk. These consensus guidelines aim to provide pragmatic advice regarding these issues. They are divided into sections on risks of untreated illness in pregnancy; general principles of using drugs in the perinatal period; benefits and harms associated with individual drugs; and recommendations for the management of specific disorders.
Key Findings
1
It emphasizes balancing risks of untreated maternal mental illness against medication effectiveness and potential fetal or infant exposure risks.
2
It evaluates benefits and harms associated with individual psychotropic medications.
3
Specific management recommendations are provided for different psychiatric disorders during the perinatal period.
4
The consensus guidance addresses clinical decisions about psychotropic medication use before conception, during pregnancy, and postpartum.
5
The guidance provides pragmatic principles for psychotropic drug use during the perinatal period, including exposure through breast milk.
Research Object
Psychotropic medication use in women with mental health problems during preconception, pregnancy, and postpartum
Research Subject
The risks, benefits, effectiveness, and management principles of psychotropic medication and untreated mental illness, including fetal/infant exposure during pregnancy and breastfeeding
Publication Details
Publication Date
2017-04-25
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest